Literature DB >> 3519467

Relative functional activity of purified human immunoglobulin G against a type III group B streptococcal strain.

K S Kim, J H Kang, N F Concepcion, B F Anthony.   

Abstract

Human immunoglobulin G (IgG) separated from whole serum by a quaternary aminoethyl-Sephadex A-50 ion exchanger was evaluated for its activity against a type III group B streptococcal strain in the newborn rat model. Separated IgG yielded approximately 70 to 80% of whole serum IgG and did not contain detectable IgM or IgA. This IgG preparation also contained similar ratios of specific type III group B streptococcal antibody to total IgG in comparison with whole serum. In vivo, 50% protection from death was achieved by 3.9 ng of type III-specific antibody per 10 g of rat body weight. This value was considerably lower than 50% protective doses obtained in our previous studies with different human IgG preparations. Further studies are needed to understand the mechanisms responsible for these differences in the functional activity of IgG antibody.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519467      PMCID: PMC260948          DOI: 10.1128/iai.52.3.908-910.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  6 in total

1.  Separation of immunoglobulin M (IgM) essentially free of IgG from serum for use in systems requiring assay of IgM-type antibodies without interference from rheumatoid factor.

Authors:  R B Johnson; R Libby
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

2.  Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.

Authors:  K S Kim; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

3.  Efficacy of imipenem in experimental group B streptococcal bacteremia and meningitis.

Authors:  K S Kim
Journal:  Chemotherapy       Date:  1985       Impact factor: 2.544

4.  Opsonic activity of immunoglobulin prepared for intravenous use.

Authors:  S V Hetherington; G S Giebink
Journal:  J Lab Clin Med       Date:  1984-12

5.  Decreased protective efficacy of reduced and alkylated human immune serum globulin in experimental infection with Haemophilus influenzae type b.

Authors:  J R Schreiber; V A Barrus; G R Siber
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

6.  Penicillin tolerance in group B streptococci isolated from infected neonates.

Authors:  K S Kim; B F Anthony
Journal:  J Infect Dis       Date:  1981-11       Impact factor: 5.226

  6 in total
  1 in total

1.  Estimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection.

Authors:  D E Schiff; C A Wass; S J Cryz; A S Cross; K S Kim
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.